Deutsche Bank Reiterates “€22.00” Price Target for Rhoen Klinikum (RHK)

Rhoen Klinikum (ETR:RHK) received a €22.00 ($26.19) price target from investment analysts at Deutsche Bank in a research report issued to clients and investors on Monday. The firm currently has a “neutral” rating on the stock. Deutsche Bank’s price target would indicate a potential downside of 29.08% from the stock’s previous close.

Several other analysts also recently issued reports on RHK. Baader Bank set a €24.00 ($28.57) price target on Rhoen Klinikum and gave the stock a “neutral” rating in a report on Friday, November 10th. Commerzbank set a €25.00 ($29.76) target price on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Friday, November 10th. Warburg Research set a €26.30 ($31.31) price objective on Rhoen Klinikum and gave the stock a “neutral” rating in a research note on Tuesday, November 7th. Berenberg Bank set a €29.15 ($34.70) price objective on Rhoen Klinikum and gave the stock a “neutral” rating in a research note on Monday, November 6th. Finally, Independent Research set a €32.00 ($38.10) price objective on Rhoen Klinikum and gave the stock a “neutral” rating in a research note on Monday, November 13th. Four investment analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of €25.05 ($29.82).

Shares of Rhoen Klinikum (ETR:RHK) opened at €31.02 ($36.93) on Monday. The firm has a market capitalization of $2,080.00 and a P/E ratio of 1,551.00. Rhoen Klinikum has a 12 month low of €22.66 ($26.98) and a 12 month high of €31.24 ($37.19).

ILLEGAL ACTIVITY NOTICE: “Deutsche Bank Reiterates “€22.00” Price Target for Rhoen Klinikum (RHK)” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/22/deutsche-bank-reiterates-22-00-price-target-for-rhoen-klinikum-rhk.html.

About Rhoen Klinikum

RH??N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply